Allison Rhines on JLabs' innovation, AI in drug discovery, and healthcare tech trends | E30

Allison Rhines joins Jack Crawford to discuss her career in infectious disease modeling and the strategic focus of JLabs in collaboration with Johnson & Johnson. They delve into the role of digital health, capital efficiency, and AI in drug discovery. Allison describes JLabs' global reach, its history, and support for early-stage startups. The episode highlights the mentorship provided by J&J, the scouting and selection process, and the qualities JLabs values in potential companies. Emerging tech trends in healthcare, particularly in early cancer detection and precision oncology, are explored. The episode concludes with insights into personal and professional development in the industry.